Pfizer and Moderna Look to Put COVID Bust Behind Them, Add New Drug Development to Pipelines
Several drugmakers whose sales boomed on COVID-19 vaccines and related products in 2021 and 2022 have now been embroiled in a hangover…
McAlinden Research PartnersOctober 18, 2023
